Polydrug Laboratories Private Limited

Polydrug Laboratories Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U24231MH2004PTC147729 Incorporated 28 July 2004 ROC Mumbai HQ Mumbai, Maharashtra, India
Converted to LLP Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹41.72 Cr
▲ 238% YoY
Net profit · FY 2024
₹16.16 Cr
Net margin 38.7%
EBITDA · FY 2024
₹18.69 Cr
EBITDA margin 44.8%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹2.04 Cr
Issued & subscribed
Satisfied charges
₹55.33 Cr
No open charges
Company age
22 yrs
Est. 2004
Employees · EPFO
5
Provident fund records

About Polydrug Laboratories Private Limited

Data last updated:

Polydrug Laboratories Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 28 July 2004.

The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH2004PTC147729. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹10 Cr and a paid-up capital of ₹2.04 Cr. It was formerly known as Polydrug Laboratories India Private Limited. It was led by directors Punit Chunilal Thakrar (Managing Director) and Bina Punit Thakrar.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Marathon Futurex A – 704(A) 7th Floor Mafatlal Mill Compound N M Joshi Marg, Mumbai, Maharashtra, India – 400013.

As per the financials filed for FY 2024, the company reported a revenue of ₹41.72 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹16.16 Cr (net margin 38.7%) and EBITDA of ₹18.69 Cr (EBITDA margin 44.8%). Revenue has declined at a compounded annual rate (CAGR) of 27% over three years and 1% over five years.

The company has about 5 employees on its provident fund (EPFO) records.

As per MCA filings, the company has satisfied charges of ₹55.33 Cr on record. Court records list 10 cases involving the company, including 7 filed by the company and 2 filed against it.

The last known website on record is polydrug.com.

Company Details of Polydrug Laboratories Private Limited
CIN U24231MH2004PTC147729
Registration Number 147729
Incorporation Date 28 July 2004
ROC Mumbai
Listing Status Unlisted
Company Status Converted to LLP
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Marathon Futurex A – 704(A) 7th Floor Mafatlal Mill Compound N M Joshi Marg, Mumbai, Maharashtra, India – 400013
  • Industry
    Pharma, API Manufacturers
Comprehensive company report
Polydrug Laboratories Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Polydrug Laboratories Private Limited report

Financials, compliance, directors, charges, ownership and filings for Polydrug Laboratories Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Polydrug Laboratories Private Limited

The main business activity of Polydrug Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Polydrug Laboratories Private Limited FY 2024 filings available

Polydrug Laboratories Private Limited reported revenue of ₹41.72 Cr (up 238% YoY) for FY 2024.

Revenue · FY 2024
₹41.72 Cr ▲ 238%
Net profit · FY 2024
₹16.16 Cr margin 38.7%
EBITDA · FY 2024
₹18.69 Cr margin 44.8%

Compounded Annual Growth Rate (CAGR) of Polydrug Laboratories Private Limited

Revenue CAGR growth
1 year
▲ 238%
3 years · compounded
▲ 27%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▲ 300%
3 years · compounded
▲ 18%

Revenue rose 238% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 300% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Polydrug Laboratories Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue₹41.72 Cr••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹18.69 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹16.16 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Polydrug Laboratories Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin44.8%••••••••••••••••
Net Profit Margin38.7%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Polydrug Laboratories are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Polydrug Laboratories Private Limited

Polydrug Laboratories has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Bina Punit ThakrarDirector01 Dec 201015 Years 10 MonthsAs last reported
Punit Chunilal ThakrarManaging Director28 Jul 200422 Years 2 MonthsAs last reported

Peer Comparison of Polydrug Laboratories Private Limited

Polydrug Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Basic Pharma Life Science Private Limited₹42.57 Cr (FY 2024)••••••••-24.0%••••Bharuch, Gujarat, India
Allastir Private Limited₹42.05 Cr (FY 2024)••••••••-3.0%••••Chennai, Tamil Nadu, India
Keshar Emulsion Private Limited₹41.86 Cr (FY 2024)••••••••-23.0%••••Ahmedabad, Gujarat, India
Hi Tech Biosciences India Private Limited₹41.75 Cr (FY 2025)••••••••24.0%••••Pune, Maharashtra, India
Jai Lara Drugs Private Limited₹41.75 Cr (FY 2025)••••••••9.0%••••Hyderabad, Telangana, India
Polydrug Laboratories Private Limited this company₹41.72 Cr (FY 2024)••••••••238.0%••••Mumbai, Maharashtra, India
Phanicare Pharmaceuticals Private Limited₹41.7 Cr (FY 2024)••••••••-18.0%••••Hyderabad, Telangana, India
Qualikems Lifesciences Private Limited₹41.7 Cr (FY 2025)••••••••13.0%••••Vadodara, Gujarat, India
Accrete Pharmaceuticals Private Limited₹41.49 Cr (FY 2025)••••••••19.0%••••Hyderabad, Telangana, India
Assurgen Pharma Private Limited₹41.36 Cr (FY 2025)••••••••-3.0%••••Visakhapatnam, Andhra Pradesh, India
Elixir Pharma Chem Private Limited₹41.04 Cr (FY 2025)••••••••86.0%••••Ahmedabad, Gujarat, India

Peers are the five companies nearest above and the five nearest below Polydrug Laboratories by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Polydrug Laboratories Private Limited

Polydrug Laboratories Private Limited is audited by Shah Modi Katudia & Co. LLP for the financial year 2024.

NameStatusAppointment DateCessation Date
Shah Modi Katudia & Co. LLPLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Polydrug Laboratories Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Polydrug Laboratories Private Limited

Open charges
None
Satisfied charges
₹55.33 Cr
Breakdown by lending institutions
Tamilnad Mercantile Bank Limited₹42.83 Cr
Tamilnad Mercantile Bank Ltd₹7.00 Cr
Axis Bank Limited₹3.50 Cr
Tamilnad Mercantile Bank Ltd.₹2.00 Cr
Latest charge details
DateLenderAmountStatus
16 Feb 2013Axis Bank Limited₹3.5 CrSatisfied
12 Feb 2013Tamilnad Mercantile Bank Limited₹1.46 CrSatisfied
24 Apr 2012Tamilnad Mercantile Bank Limited₹1 CrSatisfied
23 Jan 2012Tamilnad Mercantile Bank Limited₹5.5 CrSatisfied
17 Jan 2012Tamilnad Mercantile Bank Limited₹5.54 CrSatisfied

Total charge records: 18 View all charges

MSME Payment Delays by Polydrug Laboratories Private Limited

Polydrug Laboratories Private Limited has 8 MSME Form 1 returns on record between 2020 and 2023, listing 58 overdue payments to 37 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 37)

SupplierAmount dueDue sinceReported on
an individual supplier••••••••••••
an individual supplier••••••••••••
Precision Adhesive Tapes Private Limited••••••••••••
Aristo Raw Pharma Private Limited••••••••••••
Archk Pharma Co••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 8 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Employees and EPFO Compliance at Polydrug Laboratories Private Limited

Polydrug Laboratories Private Limited has a workforce of 5 employees as of Feb 13, 2026.

Employee count
5
Active EPFO establishments
1
Employee growth
400%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Polydrug Laboratories Private Limited

Polydrug Laboratories Private Limited has 7 board changes on record since 2004: 2 appointments and 5 cessations. The latest: Punit Chunilal Thakrar ceased to be Managing Director on 31 Mar 2019.

AGM
Polydrug Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Polydrug Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge registered on 23 Jul 2008 via Charge ID 10115482 with Tamilnad Mercantile Bank Limited was fully satisfied on 03 Dec 2019.
Charges
A charge with Tamilnad Mercantile Bank Limited of Rs. 0.37 Cr registered on 23 Jul 2008 with Charge ID 10115482 was modified on 03 May 2019.
Ceased
Punit Chunilal Thakrar ceased to be Managing Director.
Ceased
Sanjog Sadananad Parab ceased to be Director.
Ceased
Kaustabha Narayan Dey ceased to be Director.
Charges
A charge registered on 16 Feb 2013 via Charge ID 10408153 with Axis Bank Limited was fully satisfied on 18 Oct 2017.
Charges
A charge registered on 09 Jun 2011 via Charge ID 10294739 with Tamilnad Mercantile Bank Limited was fully satisfied on 03 Oct 2017.
Charges
A charge registered on 09 May 2007 via Charge ID 10053481 with Tamilnad Mercantile Bank Limited was fully satisfied on 03 Oct 2017.
Charges
A charge with Axis Bank Limited of Rs. 3.50 Cr registered on 16 Feb 2013 with Charge ID 10408153 was modified on 27 Feb 2017.
Ceased
Chandrikaben Chunilal Thakrar ceased to be Additional Director.

40 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Polydrug Laboratories Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Polydrug Laboratories Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Polydrug Laboratories Private Limited

Polydrug Laboratories has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Polydrug Laboratories Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Polydrug Laboratories Private Limited

Polydrug Laboratories has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.

Polydrug Laboratories was a private limited company based in Mumbai, Maharashtra, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 28 July 2004 and is registered under CIN U24231MH2004PTC147729. For the latest details, refer to the successor LLP entity.

The CIN (Corporate Identification Number) of Polydrug Laboratories is U24231MH2004PTC147729. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Polydrug Laboratories had 2 directors:

Polydrug Laboratories was incorporated on 28 July 2004. It is registered with the Registrar of Companies, Mumbai.

Polydrug Laboratories can be reached through the website polydrug.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Polydrug Laboratories is at Marathon Futurex A – 704A 7th Floor Mafatlal Mill Compound N M Joshi Marg, Mumbai, Maharashtra, India – 400013.

Polydrug Laboratories reported revenue of ₹41.72 Cr for FY 2024 (up 238% YoY).

Polydrug Laboratories has an authorised share capital of ₹10 Cr and a paid-up capital of ₹2.04 Cr.

Polydrug Laboratories reported a net profit of ₹16.16 Cr (net margin 38.7%) and EBITDA of ₹18.69 Cr (EBITDA margin 44.8%) for FY 2024, as per its filed financial statements.

No. Polydrug Laboratories has 1 GST registration on record and it is cancelled or inactive.

Polydrug Laboratories operated in the pharma industry, in the api manufacturers segment.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available